Bill hearing comes after the state Division of Public Health said it must reduce select services for residents with HIV due ...
MACON, Ga. — As people recognize World AIDS Day on Dec.1, attention turns to the strides made in HIV prevention, including the groundbreaking role of the PrEP pill. Approved by the FDA 12 years ago, ...
Local health officials report a decline in HIV prevalence, with new cases dropping below 200. The Women's Collective plays a ...
Please provide your email address to receive an email when new articles are posted on . PrEP coverage in the U.S. between 2012-2021 ranged from 3.8% in West Virginia to 22.2% in New York. Australian ...
Dr. Ruth Madievsky is terrified for her patients. As a clinical pharmacist who specializes in HIV care, she has watched the people she works with react in real time to the Trump administration’s ...
Gilead Sciences is no stranger to making history in HIV. Twelve years after the drugmaker pushed the first pre-exposure prophylaxis (PrEP) HIV med, Truvada, over the FDA finish line, new results from ...
A single positive HIV viral load test often falsely identified HIV infection in people who were using long-acting cabotegravir (Apretude) for preexposure prophylaxis (PrEP), according to results from ...
Gilead Sciences is wasting no time in promoting worldwide access to its twice-yearly pre-exposure prophylaxis (PrEP) HIV candidate lenacapavir. Before filing for global regulatory approvals, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results